E150430976Ann.indd

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities nor is it calculated to invite any such offer or invitation.
Neither this announcement nor any copy thereof may be released into or distributed in the United States or any other jurisdiction where such release or distribution might be unlawful. The securities referred to herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or the laws of any state or jurisdiction of the United States and may not be offered or sold in the United States absent registration or an applicable exemption from, or transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state laws. Any public offering of securities to be made in the United States will be made by means of a prospectus. Such prospectus will contain detailed information about the company making the offer and its management and financial statements. Shandong Weigao Group Medical Polymer Company Limited does not intend to register any securities described herein in the United States or to conduct a public offering of securities in the United States.

Shandong Weigao Group Medical Polymer Company Limited *

(a joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 1066) ANNOUNCEMENT CLOSURE OF REGISTER OF MEMBERS AND RECORD DATE

Reference is made to the announcement (the "Announcement") of the Company dated

23 February 2015 in relation to, inter alia, the Proposed Spin-off. Terms used herein have the same meanings as those defined in the Announcement.

* For identification purpose only

1

The Board would like to announce that the register of members of the Company will be closed from 16 May 2015 (Saturday) (the "Record Date") to 15 June 2015 (Monday) (both days inclusive) for the purpose of determining the entitlement of the qualifying Shareholders to the preferential offer for subscription of the Weigao Ortho Shares (the "Preferential Offering"). No transfer of H Shares may be registered during the closure of the register of members of the Company.

In order to qualify for the Preferential Offering, all transfers of H Shares accompanied by the relevant share certificates and transfer forms must be lodged with the Company's H Share registrar, Tricor Standard Limited, at 22nd Floor, Hopewell Centre, 183 Queen's Road East, Hong Kong for registration not later than 4:30 p.m. on 15 May 2015 (Friday) (or such later date as the Board may determine and announce).

The Board may determine another date for closure of the register of members of the Company and as the Record Date for the determination of assured entitlements to the Preferential Offering, subject to the timetable of the Proposed Spin-off, in which case a further announcement will be made to inform the Shareholders, as and when appropriate.

The listing of the Weigao Ortho Shares pursuant to the Proposed Spin-off is subject to, amongst others, the Listing Approval and the final decisions of the Board and of the board of directors of Weigao Ortho which are dependent upon, among others, market conditions during the period leading up to the proposed Global Offering. Accordingly, Shareholders and potential investors of the Company should be aware that there is no assurance that the Proposed Spin-off and the separate listing of the Weigao Ortho Shares will take place or as to when it may take place. Shareholders and potential investors of the Company should therefore exercise caution when dealing in or investing in the securities of the Company.

By Order of the Board

Shandong Weigao Group Medical Polymer Company Limited Chen Xue Li

Chairman

Weihai, Shandong, the PRC, 30 April 2015

2

As at the date of this announcement, the Board comprises of:

Mr. Zhang Hua Wei (Executive Director)

Mr. Wang Yi (Executive Director)

Mr. Gong Jian Bo (Executive Director)

Mr. Xia Lie Bo (Executive Director)

Mr. Chen Xue Li (Non-executive Director)

Mrs. Zhou Shu Hua (Non-executive Director)

Mr. Lo Wai Hung (Independent non-executive Director)

Mr. Li Jia Miao (Independent non-executive Director)

Mrs. Fu Ming Zhong (Independent non-executive Director)

Mrs. Wang Jin Xia (Independent non-executive Director)

3

distributed by